CEACAM5 and lung cancer: Decreased plasma HSP70 level combined with elevated classical circulating biomarkers CEA and CA 19-9, correlated closely with diagnosis of lung cancer, and combination of HSP70, CEA, and CA19-9 also contributed to early (stage I and II) diagnosis of lung cancer.